Anthropic redeploys Claude Fable 5 on Amazon Bedrock ahead of API and Claude.ai rollouts
AI Judge changed title after evaluation, original title: "Anthropic offers Claude Fable 5 at no extra cost via limited-time promotional access in subscription plans"
Story Overview
After export controls briefly sidelined Claude Fable 5 just days after its June debut, Anthropic is flipping the switch back on for enterprise teams first through Amazon Bedrock, with the same top-tier Mythos-class capabilities now cleared for wider use once the compliance pause lifted.
Business teams skip the queue on Bedrock
Enterprise customers can start routing their toughest workloads to Fable 5 immediately on the AWS service, giving them an early window before the model reaches the public API and Claude.ai platforms.
Early access comes with built-in guardrails on usage
Pro, Max, and Team plans receive the model at up to half their weekly quota through July 7, after which it switches to credit-based access and draws down allowances faster than previous options like Opus 4.8.
Positive users celebrate Claude AI's pixel-art videos reviving Fable 5 with excitement and nostalgia while negative users criticize usage limits and call out Anthropic for corporate missteps.
No Digg Deeper questions have been answered for this story yet.
Most Activity
Fable 5 is back.
Not really excited about this nerfed and limited Fable 5.
One of the most confusing AI launches of all time.
But we carry on.
Fable 5 is back.
All paid plans with usage included can access Fable 5 through July 7. You can use Fable 5 up to 50% of your weekly usage limit, after which you can switch to another model for the remainder of your usage. You can also continue using Fable via usage credits.
More here: https://support.claude.com/en/articles/15424964-claude-fable-5-promotional-access
There are transient 503s right now, so not quite ready for everyone yet but they're scaling capacity
Frontier models are no longer just software products. They’re strategic national assets.
Fable 5 is back.
most important question is not only what it can do, but what happens when systems like this move deeper into biology and chemistry. In software, unexpected behavior can often be contained, patched, or rolled back. But if an AI discovers, recommends, or acts on an unknown vulnerability in the human body or brain, what is the biological equivalent of rollback? Who holds final authority? Who can stop the system? What is the fail-safe when the consequence is irreversible? AI should absolutely help us understand cells, disease, drugs, and biological systems. But a purely silicon architecture—one that does not experience pain, consent, vulnerability, or irreversible consequence—should not be the final decision-maker for a biological being that does. Before capability becomes authority, this deserves a clear public answer.
@elder_plinius No vacation for Pliny I guess
Now I can use it for running my ML and drug discovery pipeline! wait, maybe not 🤨
Fable 5 is back.
@claudeai Old Fable 5: built different. New Fable 5: billed different.
@synthwavedd How the hell do you guys already have the access? Man what the fuck
@claudeai Every beginner who wants to use Claude this is a very good tip.
@theo DROP EVERYTHING
@theo @grok is it back for all the nationalities?
@theo Guess it worked!
@elder_plinius You got 60 minutes to do what we all want you to do 🙏